CFTR modulators have revolutionized the treatment of CF from symptomatic therapy, consisting of antibiotics, bronchodilators and mucolytic medicines, to mechanism-targeting therapies (Lopes-Pacheco, 2016; Cystic Fibrosis Foundation, 2021b). The gene discussed is CFTR; the disease is cystic fibrosis.